EMA Withdrawn: Atazanavir Krka (atazanavir (as sulfate)) — Krka, d.d., Novo mesto

View source ↗

Summary

EMA withdrew the Atazanavir Krka product (atazanavir sulfate) for HIV infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Atazanavir Krka (atazanavir sulfate)

Snippet

Status: Withdrawn. Therapeutic area: HIV Infections. MAH: Krka, d.d., Novo mesto. Decision date: 03/06/2025